David Johnson
2018 - Global Blood Therapeutics
In 2018, David Johnson earned a total compensation of $4.4M as Chief Commercial Officer at Global Blood Therapeutics.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Non-Equity Incentive Plan | $169,000 |
| Option Awards | $1,898,534 |
| Salary | $355,000 |
| Stock Awards | $1,897,750 |
| Other | $5,000 |
| Total | $4,394,284 |
Johnson received $1.9M in option awards, accounting for 43% of the total pay in 2018.
Johnson also received $75K in bonus, $169K in non-equity incentive plan, $355K in salary, $1.9M in stock awards and $5K in other compensation.
Rankings
In 2018, David Johnson's compensation ranked 2,447th out of 14,244 executives tracked by ExecPay. In other words, Johnson earned more than 82.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,447 out of 14,244 | 83rd |
Division Manufacturing | 901 out of 5,765 | 84th |
Major group Chemicals And Allied Products | 306 out of 2,128 | 86th |
Industry group Drugs | 248 out of 1,817 | 86th |
Industry Pharmaceutical Preparations | 191 out of 1,391 | 86th |
Source: SEC filing on April 28, 2021.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2018.